Ronald Alvarez, MD

University of Alabama

AlvarezRonald D. Alvarez, MD, is Professor and Director of the Division of Gynecologic Oncology at the University of Alabama at Birmingham (UAB).  He received his B.S. in Zoology from Louisiana State University in 1979 and his M.D. from Louisiana State University Medical Center in New Orleans in 1983. His postgraduate training included a residency in Obstetrics and Gynecology (1987) and fellowship in Gynecologic Oncology (1990) both completed at UAB.  After completing his training, he remained on the faculty of the UAB Department of Obstetrics and Gynecology, where he currently serves as Vice-Chairman and holds the Ellen Gregg Shook Culverhouse Chair.

His long-term research interests have included the development of novel therapeutics for ovarian cancer and new screening and prevention strategies for cervical cancer.  He has been the recipient of several NCI and other industry funded grants in support of his research in gene therapeutics for ovarian cancer and he is currently a co-principal investigator in cervical neoplasm vaccine projects included in the John Hopkins/UAB Cervical SPORE.

Dr. Alvarez has published over 200 articles in various peer-reviewed journals and he is on the editorial board of Gynecologic Oncology. He currently serves as co-chair of Gynecologic Oncology Group Protocol Development Committee and has served until recently on its Board of Directors.  He is on the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology and has served on study sections for the NCI and the Department of Defense Ovarian Cancer Research Program. He has also served on the Executive Committee of the Gynecologic Cancer Foundation and is currently President of the Society of Gynecologic Oncology.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

The CDC recently announced that fewer than half of American children are given the HPV vaccination.

Research

As of the July 23 deadline, 55 research abstracts were submitted in hopes of receiving one of only 6 grants from the Foundation. This points to a need for more funding so that the Foundation may award grants to every deserving applicant.

Education

The Gynecologic Cancer Global Health Forum will be Saturday, Sept. 6, 2014 in D.C.. For more information on educational events and courses, click here.